Post-transcriptional silencing of BCL11A as an effective genetic treatment in Sickle Cell Disease
Channel: Genomics In India
Date: 06/03/2021

Prof. David A. Williams, M.D.
Chief of Hematology/Oncology
Harvard Medical School